Epigenetic Regulations of Cancer Stem Cells by the Aryl Hydrocarbon Receptor Pathway
Compelling evidence has demonstrated that tumor bulk comprises distinctive subset of cells generally referred as cancer stem cells (CSCs) that has been proposed as a strong sustainer and promoter of tumorigenesis and therapeutic resistance. These distinguished properties of CSCs have raised interest...
محفوظ في:
| المؤلف الرئيسي: | Sabah, Akhtar (author) |
|---|---|
| مؤلفون آخرون: | Hourani, Shireen (author), Therachiyil, Lubna (author), Al-Dhfyan, Abdullah (author), Agouni, Abdelali (author), Zeidan, Asad (author), Uddin, Shahab (author), Korashy, Hesham M. (author) |
| التنسيق: | article |
| منشور في: |
2020
|
| الموضوعات: | |
| الوصول للمادة أونلاين: | http://dx.doi.org/10.1016/j.semcancer.2020.08.014 https://www.sciencedirect.com/science/article/pii/S1044579X2030184X?v=s5 http://hdl.handle.net/10576/16859 |
| الوسوم: |
إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
|
مواد مشابهة
-
Epigenetic Regulation of Cancer Stem Cells by the Aryl Hydrocarbon Receptor Pathway
حسب: Sabah Akhtar (5809925)
منشور في: (2022) -
Regulation of the aryl hydrocarbon receptor in cancer and cancer stem cells of gynecological malignancies: An update on signaling pathways
حسب: Lubna Therachiyil (4246156)
منشور في: (2022) -
Unlocking the secrets: exploring the influence of the aryl hydrocarbon receptor and microbiome on cancer development
حسب: Menatallah Rayan (14151360)
منشور في: (2024) -
Metformin attenuates V-domain Ig suppressor of T-cell activation through the aryl hydrocarbon receptor pathway in Melanoma: In Vivo and In Vitro Studies
حسب: Fawaz E., Alanazi
منشور في: (2021) -
Crosstalk between aryl hydrocarbon receptor (AhR) and BCL-2 pathways suggests the use of AhR antagonist to maintain normal differentiation state of mammary epithelial cells during BCL-2 inhibition therapy
حسب: Abdullah, Al-Dhfyan
منشور في: (2022)